BioInvent to Supply Critical Antibodies for Orbus Medical Technology´s Innovative Genous Bio-engineered Surface
Following successful process development at BioInvent and product approval, Orbus intends to enter into a long term supply agreement for the commercial grade antibody with BioInvent. Commenting on the deal Svein Mathisen, CEO of BioInvent, said, "we are pleased to be able to support the final stages of Orbus´ innovative product development as well as offer long term supply of the key component. We see this agreement as another brick in the implementation of our CMO strategy. We are confident that our efforts to improve our manufacturing capabilities and activities from development to commercial scale are benefiting our clients as well as our own projects."
Orbus´ Vice President of Operations and Finance, Wayne Johnson, commented, "this technology is of critical importance to our future as a company and we obviously need a reliable, secure business partner for the supply of the antibodies. We are comfortable that BioInvent meets these criteria and look forward to establishing a long-term relationship."
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous